GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » TFBS Bioscience Inc (ROCO:6939) » Definitions » Float Percentage Of Total Shares Outstanding

TFBS Bioscience (ROCO:6939) Float Percentage Of Total Shares Outstanding : 0.00% (As of May. 04, 2025)


View and export this data going back to 2023. Start your Free Trial

What is TFBS Bioscience Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, TFBS Bioscience's float shares is 0.00 Mil. TFBS Bioscience's total shares outstanding is 34.94 Mil. TFBS Bioscience's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, TFBS Bioscience's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, TFBS Bioscience's Institutional Ownership is 0.00%.


TFBS Bioscience Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

TFBS Bioscience's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/34.94
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TFBS Bioscience Business Description

Industry
Traded in Other Exchanges
N/A
Address
No. 103, Lane 169, Kang-ning Street, 3rd Floor, Xizhi District, New Taipei, TWN
TFBS Bioscience Inc is a Contract Research Organization (CRO) providing biological testing in Taiwan. Its services include viral vector manufacturing for cell and gene therapy products and biosafety testing and product release testing for cell and gene therapy products, vaccines, and biologic products.

TFBS Bioscience Headlines

No Headlines